Orient Herbs Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 24-12-2024
- Paid Up Capital ₹ 4.95 M
as on 24-12-2024
- Company Age 31 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.65 Cr
as on 24-12-2024
- Revenue 135.62%
(FY 2022)
- Profit 102.92%
(FY 2022)
- Ebitda 1168.70%
(FY 2022)
- Net Worth 26.02%
(FY 2022)
- Total Assets -0.66%
(FY 2022)
About Orient Herbs
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.95 M.
The company currently has active open charges totaling ₹8.65 Cr.
Gurnam Kaur, Sushil Kumar, Sohan Kundlas, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24233HP1993PLC013251
- Company No.
013251
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
21 Apr 1993
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- Location
Solan, Himachal Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Orient Herbs?
Board Members(5)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Gurnam Kaur | Director | 19-May-2010 | Current |
Sushil Kumar | Additional Director | 15-Sep-2016 | Current |
Sohan Kundlas | Additional Director | 15-Sep-2016 | Current |
Madan Lal | Director | 01-Nov-1998 | Current |
Harbhajan Singh | Director | 01-Nov-1998 | Current |
Financial Performance of Orient Herbs.
Orient Herbs Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 135.62% increase. The company also saw a substantial improvement in profitability, with a 102.92% increase in profit. The company's net worth Soared by an impressive increase of 26.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Orient Herbs?
In 2021, Orient Herbs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Risehigh Constructions Private LimitedActive 5 years 3 months
Sushil Kumar and Sohan Kundlas are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 16 Jun 2010 | ₹3.90 Cr | Open |
Punjab National Bank Creation Date: 16 Jun 2010 | ₹5.00 M | Open |
Punjab National Bank Creation Date: 16 Jun 2010 | ₹3.75 Cr | Open |
How Many Employees Work at Orient Herbs?
Unlock and access historical data on people associated with Orient Herbs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Orient Herbs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orient Herbs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.